Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06645470

Muscle and Movement With Anti-Obesity Medications

Led by University of Kansas Medical Center · Updated on 2026-05-11

40

Participants Needed

1

Research Sites

91 weeks

Total Duration

On this page

Sponsors

U

University of Kansas Medical Center

Lead Sponsor

N

National Institute of General Medical Sciences (NIGMS)

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this clinical trial is to learn about changes in body composition related to obesity medication use, and whether aerobic or resistance exercise training will impact these body composition changes. It will also provide information about whether aerobic or resistance exercise training has additional benefits on other health and fitness measurements. The main questions it aims to answer are: * Is there a difference in the change in body composition (fat mass, lean mass, muscle mass, and bone content) between the standard medical care and the exercise conditions (aerobic training and resistance training)? * Is there a difference in the change in body weight and BMI between the standard medical care and the exercise conditions (aerobic training and resistance training)? * Is there a difference in the change in cardiorespiratory fitness between the standard medical care and the exercise conditions (aerobic training and resistance training)? * Is there a difference in how much physical activity is completed between the standard medical care and the exercise conditions (aerobic training and resistance training)? * Is there a difference in the change in physical function between the standard medical care and the exercise conditions (aerobic training and resistance training)? * Is there a difference in the change in muscle strength between the standard medical care and the exercise conditions (aerobic training and resistance training)? * Is there a difference in the change in resting blood pressure between the standard medical care and the exercise conditions (aerobic training and resistance training)? * Is there a difference in the change in food intake between the standard medical care and the exercise conditions (aerobic training and resistance training)? * Is there a difference in the change in health-related quality of life between the standard medical care and the exercise conditions (aerobic training and resistance training)? Participants will: * Participate in an intervention for a period of 6 months that involves being assigned to a no exercise/standard medical care condition, or a supervised exercise condition (aerobic training or resistance training). * Visit the clinical before starting the study and at 6 months to complete study measurements of their body composition and other measurements to monitor their progress. * Complete a brief monitoring session at weeks 6, 12, and 18 across the 6 months. * Complete supervised exercise sessions at the research center 3x per week for 6 months (Participants in the exercise groups only: aerobic training or resistance training).

CONDITIONS

Official Title

Muscle and Movement With Anti-Obesity Medications

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 18 to under 60 years
  • Both males and females of all race/ethnic groups
  • Newly prescribed anti-obesity medication (semaglutide, tirzepatide) and planning to start and continue treatment for at least 6 months
  • Body mass index (BMI) over 27 kg/m2 with at least one weight-related complication (hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease) or BMI over 30 kg/m2 without complications
  • Able to provide informed consent
  • Cleared by study physician to participate
Not Eligible

You will not qualify if you...

  • Diagnosis of type 2 diabetes
  • More than 60 minutes per week of moderate-to-vigorous exercise or more than 1 day of structured cardiovascular or resistance exercise in past 3 months
  • Sustained weight loss over 3% in the past 3 months
  • History of metabolic or bariatric surgery
  • Pregnancy, recent pregnancy within 6 months, or planned pregnancy during study
  • Medical condition or treatment that could affect body weight or interfere with study procedures
  • History of muscle conditions affecting muscle quality or response to interventions
  • Current congestive heart failure, angina, uncontrolled arrhythmia, recent cardiovascular events, or conditions requiring chronic anticoagulation
  • Resting systolic blood pressure over 160 mmHg or diastolic over 100 mmHg unless stable on medication for over 6 months
  • Eating disorders contraindicating weight loss or physical activity
  • Alcohol or substance abuse
  • Untreated psychological conditions or recent hospitalization for psychological issues
  • Plans to relocate or commitments preventing attendance at study sessions or assessments

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Kansas Medical Center

Kansas City, Kansas, United States, 66160

Actively Recruiting

Loading map...

Research Team

R

Renee J. Rogers, Ph.D.

CONTACT

J

John M. Jakicic, Ph.D.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Muscle and Movement With Anti-Obesity Medications | DecenTrialz